345 related articles for article (PubMed ID: 18783293)
1. Multimodal cancer treatment: real time monitoring, optimization, and synergistic effects.
Myhr G
Technol Cancer Res Treat; 2008 Oct; 7(5):409-14. PubMed ID: 18783293
[TBL] [Abstract][Full Text] [Related]
2. MR guided cancer treatment system for an elevated therapeutic index - a macroscopic approach.
Myhr G
Med Hypotheses; 2008; 70(3):665-70. PubMed ID: 17765401
[TBL] [Abstract][Full Text] [Related]
3. Multimodal ultrasound mediated drug release model in local cancer therapy.
Myhr G
Med Hypotheses; 2007; 69(6):1325-33. PubMed ID: 17466462
[TBL] [Abstract][Full Text] [Related]
4. Synergistic and tumour selective effects of chemotherapy and ultrasound treatment.
Myhr G; Moan J
Cancer Lett; 2006 Feb; 232(2):206-13. PubMed ID: 16458117
[TBL] [Abstract][Full Text] [Related]
5. Smart IR780 Theranostic Nanocarrier for Tumor-Specific Therapy: Hyperthermia-Mediated Bubble-Generating and Folate-Targeted Liposomes.
Guo F; Yu M; Wang J; Tan F; Li N
ACS Appl Mater Interfaces; 2015 Sep; 7(37):20556-67. PubMed ID: 26322900
[TBL] [Abstract][Full Text] [Related]
6. Image-guided thermosensitive liposomes for focused ultrasound drug delivery: Using NIRF-labelled lipids and topotecan to visualise the effects of hyperthermia in tumours.
Centelles MN; Wright M; So PW; Amrahli M; Xu XY; Stebbing J; Miller AD; Gedroyc W; Thanou M
J Control Release; 2018 Jun; 280():87-98. PubMed ID: 29723616
[TBL] [Abstract][Full Text] [Related]
7. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
[TBL] [Abstract][Full Text] [Related]
8. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
9. The use of liposomal anticancer agents to determine the roles of drug pharmacodistribution and P-glycoprotein (PGP) blockade in overcoming multidrug resistance (MDR).
Krishna R; Mayer LD
Anticancer Res; 1999; 19(4B):2885-91. PubMed ID: 10652569
[TBL] [Abstract][Full Text] [Related]
10. A novel two-step mild hyperthermia for advanced liposomal chemotherapy.
Li L; ten Hagen TL; Haeri A; Soullié T; Scholten C; Seynhaeve AL; Eggermont AM; Koning GA
J Control Release; 2014 Jan; 174():202-8. PubMed ID: 24269966
[TBL] [Abstract][Full Text] [Related]
11. Targeting chemotherapy to solid tumors with long-circulating thermosensitive liposomes and local hyperthermia.
Ishida O; Maruyama K; Yanagie H; Eriguchi M; Iwatsuru M
Jpn J Cancer Res; 2000 Jan; 91(1):118-26. PubMed ID: 10744053
[TBL] [Abstract][Full Text] [Related]
12. Basic principles in hyperthermic tumor therapy.
Dietzel F
Recent Results Cancer Res; 1983; 86():177-90. PubMed ID: 6647999
[TBL] [Abstract][Full Text] [Related]
13. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors.
Willerding L; Limmer S; Hossann M; Zengerle A; Wachholz K; Ten Hagen TL; Koning GA; Sroka R; Lindner LH; Peller M
J Control Release; 2016 Jan; 222():47-55. PubMed ID: 26658073
[TBL] [Abstract][Full Text] [Related]
14. Radiation improves the distribution and uptake of liposomal doxorubicin (caelyx) in human osteosarcoma xenografts.
Davies Cde L; Lundstrøm LM; Frengen J; Eikenes L; Bruland S ØS; Kaalhus O; Hjelstuen MH; Brekken C
Cancer Res; 2004 Jan; 64(2):547-53. PubMed ID: 14744768
[TBL] [Abstract][Full Text] [Related]
15. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
16. Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes.
Huang SK; Stauffer PR; Hong K; Guo JW; Phillips TL; Huang A; Papahadjopoulos D
Cancer Res; 1994 Apr; 54(8):2186-91. PubMed ID: 8174126
[TBL] [Abstract][Full Text] [Related]
17. Hyperthermia mediated liposomal drug delivery.
Ponce AM; Vujaskovic Z; Yuan F; Needham D; Dewhirst MW
Int J Hyperthermia; 2006 May; 22(3):205-13. PubMed ID: 16754340
[TBL] [Abstract][Full Text] [Related]
18. Biocompatibility and therapeutic evaluation of magnetic liposomes designed for self-controlled cancer hyperthermia and chemotherapy.
Gogoi M; Jaiswal MK; Sarma HD; Bahadur D; Banerjee R
Integr Biol (Camb); 2017 Jun; 9(6):555-565. PubMed ID: 28513646
[TBL] [Abstract][Full Text] [Related]
19. MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome.
Tagami T; Foltz WD; Ernsting MJ; Lee CM; Tannock IF; May JP; Li SD
Biomaterials; 2011 Sep; 32(27):6570-8. PubMed ID: 21641639
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-induced cell permeabilisation and hyperthermia: strategies for local delivery of compounds with intracellular mode of action.
Yudina A; Moonen C
Int J Hyperthermia; 2012; 28(4):311-9. PubMed ID: 22621733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
